Leilei Chen

Author PubWeight™ 39.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Gut 2013 1.80
2 MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 2011 1.79
3 Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol 2005 1.76
4 Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One 2011 1.56
5 Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma. Hepatology 2008 1.54
6 Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. Hepatology 2010 1.47
7 SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice. Gastroenterology 2012 1.09
8 Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling. Hepatology 2013 1.09
9 Quantification of left ventricular regional myocardial function using two-dimensional speckle tracking echocardiography in healthy volunteers--a multi-center study. Int J Cardiol 2012 1.08
10 Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression. PLoS One 2012 1.05
11 Overexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. PLoS One 2011 1.02
12 Transgenic CHD1L expression in mouse induces spontaneous tumors. PLoS One 2009 0.99
13 Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma. Cancer Res 2013 0.97
14 Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma. Clin Cancer Res 2010 0.95
15 Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma. Cancer Res 2013 0.95
16 Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma. Cancer Res 2011 0.95
17 Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma. Hepatology 2012 0.94
18 Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development. Hepatology 2012 0.93
19 Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma. Cancer Res 2010 0.93
20 Toxic effects of a high dose of non-ionic iodinated contrast media on renal glomerular and aortic endothelial cells in aged rats in vivo. Toxicol Lett 2011 0.92
21 Role of translationally controlled tumor protein in cancer progression. Biochem Res Int 2012 0.91
22 Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma. Hepatology 2010 0.88
23 Characterization of a novel mechanism of genomic instability involving the SEI1/SET/NM23H1 pathway in esophageal cancers. Cancer Res 2010 0.88
24 Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma. BMC Cancer 2011 0.85
25 Hepatocellular carcinoma: transcriptome diversity regulated by RNA editing. Int J Biochem Cell Biol 2013 0.84
26 Establishment and characterization of human non-small cell lung cancer cell lines. Mol Med Rep 2011 0.83
27 Screening natural antioxidants in peanut shell using DPPH-HPLC-DAD-TOF/MS methods. Food Chem 2012 0.83
28 Expression profiles of seven glutathione S-transferase (GST) genes from Venerupis philippinarum exposed to heavy metals and benzo[a]pyrene. Comp Biochem Physiol C Toxicol Pharmacol 2012 0.83
29 RNA editome imbalance in hepatocellular carcinoma. Cancer Res 2014 0.81
30 SCYL1 binding protein 1 promotes the ubiquitin-dependent degradation of Pirh2 and has tumor-suppressive function in the development of hepatocellular carcinoma. Carcinogenesis 2012 0.80
31 Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma. Int J Cancer 2013 0.80
32 Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma. Biochem Biophys Res Commun 2013 0.80
33 ADAR1: a promising new biomarker for esophageal squamous cell carcinoma? Expert Rev Anticancer Ther 2014 0.79
34 Overexpression of eIF-5A2 in mice causes accelerated organismal aging by increasing chromosome instability. BMC Cancer 2011 0.79
35 Correction: Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1. PLoS Biol 2015 0.77
36 Substrate specificity of galactokinase from Streptococcus pneumoniae TIGR4 towards galactose, glucose, and their derivatives. Bioorg Med Chem Lett 2012 0.77
37 Responses of thioredoxin 1 and thioredoxin-related protein 14 mRNAs to cadmium and copper stresses in Venerupis philippinarum. Comp Biochem Physiol C Toxicol Pharmacol 2011 0.77
38 One-pot three-enzyme synthesis of UDP-Glc, UDP-Gal, and their derivatives. Carbohydr Res 2013 0.77
39 Molecular cloning and expression of a C-type lectin gene from Venerupis philippinarum. Mol Biol Rep 2013 0.76
40 Chemically-induced cancers do not originate from bone marrow-derived cells. PLoS One 2012 0.75
41 Transcriptional regulation of selenium-dependent glutathione peroxidase from Venerupis philippinarum in response to pathogen and contaminants challenge. Fish Shellfish Immunol 2011 0.75
42 The expression of neurofibromin in human osteoblasts and chondrocytes. Ann Clin Lab Sci 2008 0.75
43 A sputtered CdS buffer layer for co-electrodeposited Cu2ZnSnS4 solar cells with 6.6% efficiency. Chem Commun (Camb) 2015 0.75
44 Flow cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic myelogenous leukemias: a potential prognostic marker. Ann Hematol 2008 0.75